Disclosures for "Radiological features of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) and its longitudinal progression")
-
Dr. Rajagovindan has received personal compensation for serving as an employee of Biogen. Dr. Rajagovindan has received personal compensation for serving as an employee of Vigil. Dr. Rajagovindan has stock in Biogen. Dr. Rajagovindan has stock in Vigil .
-
Mr. O'Mara has received personal compensation for serving as an employee of VIgil Neuroscience, LLC.
-
Andreas Meier has received personal compensation for serving as an employee of Voyager Therapeutics. Andreas Meier has received personal compensation for serving as an employee of Biogen.
-
Mr. MacDougall has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Actinium Pharmaceuticals. Mr. MacDougall has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aura Biosciences. Mr. MacDougall has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vigil Neuro. Mr. MacDougall has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Catabasis Pharmaceuticals. Mr. MacDougall has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Edgewise Therapeutics. Mr. MacDougall has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Enterin . Mr. MacDougall has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Neurogastrx, Inc.. Mr. MacDougall has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Promentis. Mr. MacDougall has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Synlogic Therapeutics. Mr. MacDougall has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cogent Biosciences. Mr. MacDougall has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Point Biopharma. Mr. MacDougall has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenyx.
-
Dr. Finger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vigil Neuro. Dr. Finger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali Therapeutics. The institution of Dr. Finger has received research support from CIHR. The institution of Dr. Finger has received research support from Physician Servcices Incorporated. The institution of Dr. Finger has received research support from Weston Foundation. Dr. Finger has received personal compensation in the range of $500-$4,999 for serving as a Annual Meeting Course Director with American Academy of Neurology.
-
Dr. Orthmann Murphy has received research support from Conrad N. Hilton Foundation. Dr. Orthmann Murphy has received research support from Institute for Translational Medicine and Therapeutics' (ITMAT) Transdisciplinary Program in Translational Medicine and Therapeutics, University of Pennsylvania. The institution of Dr. Orthmann Murphy has received research support from Vigil Neurosciences. The institution of Dr. Orthmann Murphy has received research support from National MS Society. Dr. Orthmann Murphy has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker with Temple University . Dr. Orthmann Murphy has received personal compensation in the range of $0-$499 for serving as a Consultant with American Neurological Association.
-
Daniel Broderick has nothing to disclose.
-
Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica.
-
Spyros Papapetropoulos has nothing to disclose.